BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23348331)

  • 1. Syringocystadenocarcinoma papilliferum with squamous cell carcinoma differentiation and with locoregional metastasis.
    Arslan H; Diyarbakrl M; Batur S; Demirkesen C
    J Craniofac Surg; 2013 Jan; 24(1):e38-40. PubMed ID: 23348331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Histological Snapshot of Hypothetical Multistep Progression From Nevus Sebaceus to Invasive Syringocystadenocarcinoma Papilliferum.
    Parekh V; Guerrero CE; Knapp CF; Elmets CA; McKay KM
    Am J Dermatopathol; 2016 Jan; 38(1):56-62. PubMed ID: 26317389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Syringocystadenocarcinoma papilliferum with locoregional metastases.
    Satter E; Grady D; Schlocker CT
    Dermatol Online J; 2014 Apr; 20(4):22335. PubMed ID: 24746298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A rare tumor: syringocystadenocarcinoma papilliferum.
    Aydin OE; Sahin B; Ozkan HS; Gore O
    Dermatol Surg; 2011 Feb; 37(2):271-4. PubMed ID: 21324034
    [No Abstract]   [Full Text] [Related]  

  • 5. Syringocystadenocarcinoma papilliferum: a case report.
    Park SH; Shin YM; Shin DH; Choi JS; Kim KH
    J Korean Med Sci; 2007 Aug; 22(4):762-5. PubMed ID: 17728526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syringocystadenocarcinoma papilliferum with transition to areas of squamous differentiation: a case report and review of the literature.
    Zhang YH; Wang WL; Rapini RP; Torres-Cabala C; Prieto VG; Curry JL
    Am J Dermatopathol; 2012 Jun; 34(4):428-33. PubMed ID: 22343110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic diversity of syringocystadenocarcinoma papilliferum based on a clinicopathologic study of 6 cases and review of the literature.
    Kazakov DV; Requena L; Kutzner H; Fernandez-Figueras MT; Kacerovska D; Mentzel T; Schwabbauer P; Michal M
    Am J Dermatopathol; 2010 Jun; 32(4):340-7. PubMed ID: 20216201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Syringocystadenocarcinoma papilliferum in situ: report of a case with late recurrence.
    Castillo L; Moreno A; Tardío JC
    Am J Dermatopathol; 2014 Apr; 36(4):348-52. PubMed ID: 24394301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syringocystadenocarcinoma Papilliferum In Situ, a Variant of Cutaneous Adenocarcinoma In Situ: A Case Report With Literature Review.
    Chen J; Beg M; Chen S
    Am J Dermatopathol; 2016 Oct; 38(10):762-5. PubMed ID: 27533073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum.
    Arai Y; Kusakabe H; Kiyokane K
    J Dermatol; 2003 Feb; 30(2):146-50. PubMed ID: 12692383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syringocystadenocarcinoma papilliferum: Clinicopathologic analysis of 10 cases.
    Zhang Y; Kong YY; Cai X; Shen XX; Kong JC
    J Cutan Pathol; 2017 Jun; 44(6):538-543. PubMed ID: 28337777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic pitfalls in syringocystadenocarcinoma papilliferum: case report and review of the literature.
    Leeborg N; Thompson M; Rossmiller S; Gross N; White C; Gatter K
    Arch Pathol Lab Med; 2010 Aug; 134(8):1205-9. PubMed ID: 20670144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nevus Sebaceous of the Scalp With Stepwise Progression Into Invasive Syringocystadenocarcinoma Papilliferum.
    Kneitz H; Goebeler M; Rütten A
    Am J Dermatopathol; 2021 Dec; 43(12):965-969. PubMed ID: 34797792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syringocystadenocarcinoma papilliferum: a rare tumor with a favorable prognosis.
    Peterson J; Tefft K; Blackmon J; Rajpara A; Fraga G
    Dermatol Online J; 2013 Sep; 19(9):19620. PubMed ID: 24050294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syringocystadenocarcinoma Papilliferum in the Perianal Area.
    Iga N; Fujii H; Miyake T; Ehara M; Kore-Eda S
    Case Rep Dermatol; 2015; 7(2):84-9. PubMed ID: 26078737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Syringocystadenocarcinoma Papilliferum: A Case Report and Review of the Literature.
    Lee KG; Choi W; Lim JS; Hahn HJ; Myung KB; Cheong SH
    Ann Dermatol; 2019 Oct; 31(5):559-562. PubMed ID: 33911649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Scrotal syringocystadenoma papilliferum: case report.
    Abdulla AN; Covert AA; Grantmyre JE
    Can J Urol; 2009 Jun; 16(3):4684-6. PubMed ID: 19497181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syringocystadenocarcinoma papilliferum: case report and immunohistochemical comparison with its benign counterpart.
    Ishida-Yamamoto A; Sato K; Wada T; Takahashi H; Iizuka H
    J Am Acad Dermatol; 2001 Nov; 45(5):755-9. PubMed ID: 11606929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin.
    Langner C; Ott A
    APMIS; 2009 Feb; 117(2):148-50. PubMed ID: 19239438
    [No Abstract]   [Full Text] [Related]  

  • 20. Syringocystadenoma papilliferum: Unusual location.
    Elfatoiki F; Khadir K; Ouakadi A; Azzouzi S; Bahechar N; Benchikhi H
    Dermatol Online J; 2011 Jun; 17(6):7. PubMed ID: 21696687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.